Introduction
7 bleeding tendency (epistaxis, petechia), severe icterus, or respiratory distress that was not associated with anemia, indicating possible ARDS. These complications were diagnosed clinically and aided by further diagnostic procedures in most of the hospitalized cases. IMHA was diagnosed on a positive in-saline agglutination test. Fifteen dogs that were presented to the OVAH for routine sterilization were used as controls (Group 4).
Laboratory measurements
Excluding blood pressure determination and the echocardiography fractional shortening (FS), all data was collected at presentation and prior to any therapeutic intervention. Blood pressure determination and the FS were performed within 8 hours of admission. Two EDTA tubes, 1 serum tube, and 1 ml of heparinised blood were collected from the jugular vein from all dogs at presentation. One of the EDTA tube was centrifuged within 5 minutes) and the plasma stored at -80° C, until the NT-ProBNP assays were done. Sample collection and storage was done over 2 years. The other EDTA and the heparinised sample were used for immediate hematology and blood lactate assay, respectively.
From each animal the following parameters were determined: complete blood count (CBC), blood smear analysis, urine analysis (specific gravity, dipstick and urine sediment), serum urea, creatinine, cystatin-C, and cTnI, blood lactate, plasma NT-proBNP, FS, and blood pressure. Serum urea, creatinine and cystatin-C levels were measured to evaluate renal function as impaired renal function may lead to delayed excretion of circulating cardiac biomarkers (Boswood et al., 2008) . The urea: creatinine (UC) ratio was calculated as myocardial injury has been shown to increase the ratio (Feinfeld et al., 2002) . As lactic acidosis and poor perfusion have been shown to impair cardiac function and integrity, blood lactate and blood pressure were also evaluated in this study.
CBC was conducted on a Cell Dynn 3500 analyzer (Abbott Laboratories, Abbott Park, Illinois, USA). Serum urea and creatinine were determined on a Technicon RA 1000 system (Abbott Laboratories, Abbott Park, Illinois, USA). Blood lactate was measured using the Accusport ® blood lactate analyzer (Roche Products, Africa Region, Box 129, Isando, South Africa). Serum cystatin-C concentration was measured using the particle-enhanced turbidimetric immunoassay, according to manufacturer's instructions (Diagnostech, Honeydew Dako Cytomation, Cystatin C PET kit, Denmark). Cardiac troponin I concentrations were determined with a solid-phase, enzyme-labeled chemiluminescent immunometric assay (Immulite 2000 Troponin I, Siemens Medical Solutions Diagnostics, 5210 Pacific Concourse Drive, Los Angeles, California, USA) using cTnI-specific purified, polyclonal murine and caprine antibodies with independent immunologic epitopes for cTnI.
The detection limit was 0.2 ng/ml. The upper limit of normality for the cTnI used in this study was 1 ng/ml, which was based on the cut-off value used in humans and canine studies (Lobetti et al., 2002; Schober et al., 1999) . Plasma NT-proBNP was determined using a commercially available canine-specific NT-proBNP enzyme immunoassay (Cardiopet ® ProBNP, Idexx Laboratories, Johannesburg, South Africa) according to manufactures instructions, with values less than 210 pmol/l considered negative for heart disease, between 210 and 300 a probability of heart disease, and over 300 indicative of heart disease). For both NT-proBNP and cTnI samples, controls, and standards were performed in duplicate Echocardiography was performed with an Omnia Sonoline ultrasound machine (Siemens, Germany) using a 5MHz phased array transducer. Fractional shortening was calculated from M-mode measurements of the left ventricle and was an average of 3 measurements.
Blood pressure was determined non-invasively by an oscillometric technique, using a determine correlation between variables. The level of significance was set at p < 0.05.
Results
The median age in Group 1 was 24 months (range 7-129); Group 2, 24 months (range 6-92); Group 3, 12 months (range 3.5-60) and Group 4, 13 months (range 4-81).
Groups 3 and 4 were statistically younger that the other 2 groups. The median weight in pmol/l, 2/15 (13.3%) a value between 210 and 300, and 7/15 (46.7%) had values above 300.
In Group 2, two of the dogs (13%) had a value between 210 and 300 whereas the remaining 13/15 dogs (87%) were above 300. All dogs in group 3 had values greater than 300 pmol/l.
The cTnI results are illustrated in Figure 2 . In Group 1, 6/15 (40%) dogs had cTnI concentrations below the detection limit (0.2 ng/ml), 4/15 (26.7%) showed a concentration below the upper limit of the reference range (1 ng/ml), and 5/15 (33.3%) had elevated concentrations. The median for group 1 was 0.39 and the range 0.2-9.19. In Group 2, 7/15 (46.7%) had concentrations below the detection limit, 3/15 (20%) showed a concentration below the upper limit of the reference range, and 5/15 (33.3%) had elevated concentrations.
The median for the group was 0.4 ng/ml and the range 0.2-21.9. In Group 3, 1/15 (6.7%) had concentrations below the detection limit, 6/15 (40%) had concentrations below the upper limit of the reference range, and 8/15 (53.3%) had elevated concentrations. The median for the group was 1.45 ng/ml and the range 0.2-14.4. All dogs in the control group had concentrations below the detection limit. There was a statistically significant difference in cTnI concentration between the control group and group 3. There was no statistically significant difference between the babesiosis groups.
The median FS in Group 1 was 33.7% (range 23.2-45.5); Group 2, 43.9% (range 23.3-51.7); Group 3, 38.9% (range 19.4-59.2) and Group 4, 37.8% (range 18.4-49.6).
Although there was no statistical significance between the groups, it would appear that both groups 2 and 3 tended towards a higher FS.
Median systolic blood pressure in All 3 babesiosis groups had a statistically significant lower hematocrit than the control group and Groups 2 and 3 showed a statistically significant difference from Group 1. Five dogs in the complicated group were diagnosed with IMHA. There was, however, neither a significant difference nor a trend between the positive and the negative dogs with regards to cTnI, T-proBNP, and hematocrit. There was also no trend with dogs showing specific complications of babesiosis and cTnI, NT-proBNP, and hematocrit. In all babesiosis groups there was no correlation between the NT-proBNP and hematocrit, cTnI, FS, urea, creatinine, and lactate. Another correlation done was between the pulse and haematocrit, which showed no correlation.
All dogs recovered after treatment.
Discussion
The results of this study showed that dogs with babesiosis had elevated NT-proBNP and that the elevation was proportional to the severity of the disease. This is the first study to report such findings. NT-proBNP was selected to see if it could determine the presence of functional cardiac dysfunction before there was biochemical evidence on myocardial damage (cTnI), as histopathology was not undertaken in this study. The study showed that elevated NT-proBNP appeared to occur earlier and was independent of myocardial damage, detected by cTnI. From this study it would appear that in canine babesiosis there are functional cardiac changes before myocardial damage is evident. In babesiosis the diagnosis of heart disease is compounded by the presence of the anemic hypoxic state. The early and accurate diagnosis of heart dysfunction in dogs with babesiosis would ensure early and appropriate management. A similar situation occurs in humans with heart failure in that early diagnosis enables patients to be managed rapidly and for this reason, there has been 13 significant interest in the development of tests for biomarkers of heart disease and failure in humans patients (Boswood et al., 2008) .
In one study (Charpentier et al., 2004) , humans with sepsis and/or septic shock, systolic myocardial dysfunction with transient hypotension was a common finding. The study also showed that NT-proBNP levels were useful to detect myocardial dysfunction early in the clinical course of sepsis and persistence of high NT-proBNP levels significantly increased the risk of death. In our study serial NT-proBNP was not done, thus no conclusion could be Similarly, natriuretic peptides have been widely demonstrated to be useful as markers of the presence and severity of canine cardiac disease (Boswood et al., 2003; Boswood et al., 2008; Fine et al., 2008; Haggstrom et al., 2000; Oyama et al., 2008; Prosek et al., 2007) . In a study of 330 dogs presented with cough or dyspnea, showed that, although NT-proBNP concentrations were remarkably lower than in humans, NT-proBNP was able to discriminate between heart failure and non-heart failure as a cause for the clinical signs (even in dogs with a previous medical history of heart failure) and also correlated with severity of heart failure (De Francesco et al., 2007) . In a study in dogs with mitral valve disease, NT-proBNP was shown to be an aid in the evaluation of the symptomatic phase and provided information on both disease severity and prognosis (Serres et al., 2009 ).
Cardiac troponin has been shown to be the most sensitive and specific factor for the prediction of myocardial injury and in humans it can be detected from about 8 hours after the cardiac injury and 10 days thereafter (Collinson et al., 2000; Lee et al., 2008) , an ideal time window for clinical canine babesiosis that are usually represent within this time frame after the infection started. In our study approximately 33% of dogs with mild and severe babesiosis had elevated cTnI whereas the number increased to 53% in the complicated group. This is in agreement with previous studies where the magnitude of elevation was proportional to the severity of the disease (Dvir et al., 2004; Lobetti et al., 2002) . There was no correlation between cTnI and hematocrit and therefore unlikely that anemia caused myocardial hypoxia. As babesiosis is a hemolytic disease a severe drop in hemoglobin can occur. Several animal studies have indicated that at a hematocrit of 0.1-0.15-l/l tissue oxygenation is maintained (Weisekopf, 1995) . The critical value of hemoglobin at which oxygen delivery is equal to oxygen utilization has been shown to occur at a hematocrit of approximately 10% (van der Linden et al., 1998) . Below these levels of critical oxygen delivery, signs of circulatory collapse and shock develop. In pigs signs of shock include reduction in cardiac output, increased central venous pressure, bradycardia, decreased mixed venous saturation, arterial hyperlactatemia, and hypotension (Schou et al., 1998) . In this study a reduction in cardiac output (as determined by FS), bradycardia, hyperlactatemia, or hypotension was not evident, making shock an unlikely cause. Furthermore as there was no correlation between lactate and hematocrit it would suggest that any increase in lactate would more likely reflect changes in perfusion and/or cardiac output rather than lower oxygen carrying capacity. As expected, dogs with babesiosis had a low hematocrit, however, this did not appear to influence the cardiac biomarkers, as there was no correlation with NTproBNP and cTnI, and FS. As a dog becomes more anemic, it would be expected that heart rate and thus peripheral pulse would increase as a compensatory mechanism. There was, however, no correlation between pulse and hematocrit in this study.
Although renal dysfunction can elevate NT-proBNP, in this study there was no correlation with the urea and creatinine and serum NT-proBNP values. Only 2/15 dogs in the complicated group showed azotemia, one with evidence of acute kidney damage, which did not have a severe elevation in NT-proBNP. An increased serum creatinine concentration has been associated with an increased NT-proBNP concentration (Boswood et al., 2008) , which was not evident in this study. One study showed that dogs with renal disease had significantly higher mean serum concentration of NT-proBNP than control dogs (Schmidt et al., 2009) . Renal function should be considered when interpreting NT-proBNP results as concentrations may be falsely elevated in dogs with renal dysfunction and normal cardiac function.
In this study, dogs with complicated babesiosis showed a disproportionate increased urea with respect to creatinine. This group, as well as the dogs with severe babesiosis, also
showed an elevated UC ratio, indicative of pre-renal azotemia. Azotemia, in the form of elevated serum urea concentrations, is common in canine babesiosis (Reyers, 1992; Reyers et al, 1998) . In a retrospective canine babesiosis study, the median serum urea concentration was approximately double the normal laboratory range, whilst the median serum creatinine concentration fell within the normal range (De Scally et al., 2004) . In humans, cardiac disease has been reported to be a major contributor of an increased serum UC ratio (Feinfield et al., 2002) . As significant myocardial disease has been reported in canine babesiosis (Dvir et al., 2004; Lobetti et al., 2002) , myocardial failure may account for the increased serum UC ratio in canine babesiosis.
Babesiosis results in various degrees of anemia (Lobetti, 1998) , which will result in volume retraction and high-output states (increased preload, reduced afterload) and can result in high output heart failure. The volume overload can result in increased stretch and thus an increase in NT-proBNP. This study suggests that dogs with severe babesiosis suffer from cardiac volume overload, as this is the major cause of elevated NT-proBNP. Such elevated levels originate most probably from myocardial failure, however some of the increase can also secondary to pulmonary complications (De Lemos et al., 2001 ) that have been described in canine babesiosis (Lobetti, 1998) . In such cases the "cut off" for diagnosis of heart involvement might need to be increased (De Lemos et al., 2001) .
Although pulmonary complications occur in babesiosis (Lobetti, 1998) , in this study only two dogs showed pulmonary oedema (ARDS), without their NT-proBNP being severely elevated.
In the other dogs the presenting sign of polypnea resolved with parasite therapy and blood transfusion and none of these dogs went on to develop pulmonary complications. It is, obviously, warranted to investigate further the interrelation between the pulmonary and the cardiovascular complications in babesiosis.
The only cardiac variable assessed in this study was FS and it was determined a number of hours after the diagnosis had been made and often after therapeutic interventions had been done, thus potentially changing conventional echocardiographic variables.
Fractional shortening is the most common and easily aquired measuremnt of ventricular function and may be affected by preload, afterload and contractility (Boone 2011). In an experimentally induced acute normovolemic anemia study in conscious dogs by our babesiosis study group, which mimicked severe uncomplicated babesiosis, the increased FS was similar to the severe uncomplcated group in the current study (FS of 47.3% with a Ht of 0.15 l/l and 44% with a Ht of 0.11 l/l) (Spotswood et al., 2006) . This increased fractional shortening is indicative of increased cardiac output secondary to the hyperdynamic state that exists in severely anemic patients which improves as the anemic state improves (Spotswood et al., 2006) . Increased cardiac output is regarded as the most important compensatory mechanism in maintaining adequate tissue oxygenation, particularly in the face of moderate to severe chronic anemia where the other mechanisms are already saturated (Varat et al., 1972 ). An extensive echocardiographic examination in our critically ill groups was not deemed feasible for this study and hence only FS was determined as a bedside test to get some idea of cardiac function. Based on the experimental study mentioned previously it does not appear that the expected cardiac function changes seen in anemia were at all altered by the presence of babesiosis and that the elevated NT-proBNP most likely resulted from the increased preload with associated myocardial stretch.
In a previous study (Lobetti et al, 2002) , an association between cTnI concentration and histological changes, clinical severity, and survival was evidenced in dogs with babesiosis. The present study seems to indicate that NT-proBNP could be a more 
